Confirmation of ethanol administration in racing greyhounds by LC‐MS‐MS
Ethanol causes depression of the central nervous system and its use in professional animal racing must be controlled due to…
Synthesis and analytical characterization of 1‐(2‐thienoyl)‐6‐allyl‐nor‐d‐lysergic acid diethylamide (1T‐AL‐LAD)
Abstract Lysergic acid diethylamide (LSD) analogs have emerged as new psychoactive substances (NPS) since the mid-2010s, and new compounds continue…
In vitro activation of the CB1 receptor by the semi‐synthetic cannabinoids hexahydrocannabinol (HHC), hexahydrocannabinol acetate (HHC‐O) and hexahydrocannabiphorol (HHC‐P)
The semi-synthetic cannabinoids market is developing rapidly, and 24 European countries have identified HHC, often sold openly. This study characterized…
Issue Information
No abstract is available for this article.
FDA approves nivolumab with ipilimumab for unresectable or metastatic hepatocellular carcinoma
On April 11, 2025, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) with ipilimumab (Yervoy, Bristol…
Sunscreen Meetings
Sunscreen Meetings
Optimization of Parallel Artificial Liquid Membrane Extraction for the Determination of Over 50 Psychoactive Substances in Oral Fluid Through UHPLC–MS/MS
This study is related to the development of a microextraction method for the determination of 56 psychoactive substances in oral…
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
Other | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have been granted for supportive care products…